Genes inside the cagPAI of Helicobacter pylori are not associated with gastric cancer in Japan

Hepato-Gastroenterology

Volumn 51, Issue 57, 2004, Pages 891-894

  Nishiya, Daisuke ^b   Shimoyama, Tadashi ^a   Yoshimura, Tetsuro ^b   Tanaka, Masanori ^b   Fukuda, Shinsaku ^b   Munakata, Akihiro ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

CagPAI; Gastric cancer; Helicobacter pylori

Indexed keywords

CAGA PROTEIN; CAGE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; CHRONIC GASTRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; JAPAN; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHIZOBIUM; STOMACH CANCER;

FEMALE; GENES, BACTERIAL; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 2342532380     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al: Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90:5791-5795.
2. Crabtree JE, Farmery SM: Helicobacter pylori and gastric mucosal cytokines: evidence that cagA-positive strains are more virulent. Lab Invest 1995; 73:742-745.
3. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R: Translocation of Helicobacter pylori cagA into gastric epithelial cells by type IV secretion. Science 2000; 287:1497-1500.
4. Stein M, Rappuoli R, Covacci A: Tyrosine phoephorylation of the Helicobacter pylori cagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97:1263-1268.
5. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ: Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87:1777-1780.
6. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al: Infection of strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-2115.
7. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A: High prevalence of the cagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 1997; 32:465-468.
8. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93:14648-14653.
9. Shimoyama T, Everett SM, Dixon MF, Axon ATR, Crabtree JE: Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol 1998; 51:765-770.
10. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD: Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-□B in gastric epithelial cells. J Immunol 1998; 160:2401-2407.
11. Crabtree JE, Kersulyte D, Li SD, Lindley IJ, Berg DE: Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue. J Clin Pathol 1999; 52:653-657.
12. Peek RM Jr, Miller GG, Tham KT, Perez-Perez GI, Cover TL, Atherton JC, et al: Detection of Helicobacter pylori gene expression in human gastric mucosa. J Clin Microbiol 1995; 33:28-32.
13. Slater E, Owen RJ, Williams M, Pounder RE: Conservation of the cag pathogenicity island of Helicobacter pylori: Associations with vacuolating cytotoxin allele and IS605 diversity. Gastroenterology 1999; 117:1308-1315.
14. Umegaki N, Shimoyama T, Nishiya D, Suto T, Fukuda S, Munakata A: Clarithromycin-resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan. J Gastroenterol Hepatol 2000; 15:906-909.
15. Sharma SA, Tummuru MK, Miller GG, Blaser MJ: Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori. Infect Immun 1995; 63:1681-1687.
16. Crabtree JE, Xiang Z, Lindley IJ, Tompkins DS, Rappuoli R, Covacci A: Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol 1995; 48:967-969.
17. Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, et al: Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol 2001; 8:181-186.
18. Fallone CA, Barkun AN, Gottke MU, Best LM, Loo VG, Veldhuyzen van Zanten S, et al: Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am J Gastroenterol 2000; 95:659-669.
19. Day AS, Jones NL, Policova Z, Jennings HA, Yau EK, Shannon P, et al: cagE is a virulent factor associated with Helicobacter pylori-induced duodenal ulceration in children. J Infect Dis 2000; 181:1370-1375.
20. Sadakane Y, Kusaba K, Nagasawa Z, Tanabe I, Kuroki S, Tadano J: Prevalence and genetic diversity of cagD, cagE, and vacA in Helicobacter pylori strains isolated from Japanese patients. Scand J Gastroenterol 1999; 10:981-986.
21. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, et al: Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999; 44:336-341.
22. Jenks PJ, Megraud F, Labigne A: Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island. Gut 1998; 43:752-758.
23. Audibert C, Burucoa C, Janvier B, Fauchere JL: Implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion. Infect Immun 2001; 69:1625-1659.
24. Peters TM, Owen RJ, Slater E, Varea R, Teare EL, Saverymuttu S: Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-cagA serum antibody in UK patients with dyspepsia. J Clin Pathol 2001; 54:219-223.